| Mrs Julia B Brackeen, RPH | |
|
365 Huntley Pkwy, Pelham, AL 35124-6164 | |
| (205) 620-0691 | |
| (205) 620-0919 |
| Full Name | Mrs Julia B Brackeen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 365 Huntley Pkwy, Pelham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073851556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10479 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Julia B Brackeen, RPH 365 Huntley Pkwy, Pelham, AL 35124-6164 Ph: (205) 620-0691 | Mrs Julia B Brackeen, RPH 365 Huntley Pkwy, Pelham, AL 35124-6164 Ph: (205) 620-0691 |
News Archive
In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery.
Leica Microsystems and TrueVision® 3D Surgical announced the debut of 3D surgical microscopes at the 81st Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS).
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
The House on Tuesday passed legislation by voice vote to reauthorize trauma care programs. Traumatic injury is the top cause of death for people under age 45, according to the Centers for Disease Control. One of the bills, H.R. 4080, would reauthorize Trauma Care System Planning Grants to boost access to trauma care through fiscal 2019 (Marcos, 6/24).
Soligenix, Inc., a late-stage biopharmaceutical company, announced today promising preliminary results from a preclinical study of SGX202 in a canine gastrointestinal acute radiation syndrome model.
› Verified 1 days ago
Neil Damron, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1573 Cahaba Valley Rd, Pelham, AL 35124 Phone: 205-988-5023 Fax: 205-988-5024 | |
Dr. Charles Phillip Lawrence, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9458 Helena Rd, Pelham, AL 35124 Phone: 205-444-9488 Fax: 205-989-8478 | |
Christie Ellison Huner, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3340 Pelham Pkwy, Pelham, AL 35124 Phone: 205-664-8027 Fax: 205-664-8312 | |
Darrelle Knight Marbury, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 563 Cahaba Manor Dr, Pelham, AL 35124 Phone: 504-250-7418 | |
Ashley Stokes, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9458 Helena Rd, Pelham, AL 35124 Phone: 205-444-9488 | |
Colleen Casey Odonnell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2181 Pelham Pkwy, Pelham, AL 35124 Phone: 205-987-0301 |